Parnell Pharmaceuticals

What Parnell Pharmaceuticals does

Parnell Pharmaceuticals, Inc. is a privately held, founder-operated specialty pharmaceutical company founded in 1980 (some sources cite 1986) by Dr. Francis Parnell, an otolaryngologist, and Dr. Diana Parnell, a dermatologist — both Georgetown Medical School graduates. The company develops, manufactures, and markets over-the-counter and prescription topical products targeting mucosal and skin dryness, including Mouth Kote dry mouth spray, Pretz nasal sprays (original and preservative-free variants), and DermFresh skin preparation solution. All products are built around a patented Yerba Santa (Eriodictyon californicum) extract technology — the company holds five patents on this extract and states it is the only pharmaceutical firm utilizing Yerba Santa in patented formulations — with mucopolysaccharides that mimic glycoproteins in normal mucosa to provide lubricity and moisturization. Products are alcohol-free, gluten-free, sugar-free, cruelty-free, and registered as Class 1 Medical Devices in the USA and EU.

Parnell operates a direct-to-consumer go-to-market, selling through its own e-commerce site (parnellpharm.com), a phone-order line (800-45-PHARM), and Amazon, with a parallel professional-account channel for US healthcare providers offering special pricing and product samples. Distribution extends to physical pharmacies through the three largest US wholesalers — AmerisourceBergen, Cardinal Health, and McKesson — and to Canada through a partnership with McCaughey Consumer Products. Unit pricing is low, in the $6.25-$29.99 range, and one disclosed clinical study (University of Minnesota) reported 83% patient preference for Mouth Kote over Xero-Lube and an average relief duration of 1 hour 55 minutes. The company is headquartered in San Rafael, California, employs 11-50 people, and has remained closely held by the founding Parnells with no external institutional ownership evidenced. The only known external capital event is a $612,500 funding round dated 2016-03-03 with undisclosed investors.

The business model is therefore a niche consumer health franchise with stable cash economics, a defensible (though narrow) IP estate, and a multi-channel distribution footprint in a category defined by clinical dryness indications (xerostomia from medications, disease, surgery, irradiation, Sjogren's Syndrome, and aging; nasal dryness from altitude and environmental factors). Revenue is not publicly disclosed; the company carries no app, no public API, and uses only commodity digital infrastructure (Salesforce, Authorize.Net, Google Analytics, Google reCAPTCHA) with no AI or ML capabilities disclosed.

Name

Parnell Pharmaceuticals

Legal name

Parnell Pharmaceuticals, Inc.

Website

https://parnellpharm.com

Company type

Private

Founded year

1980

Operating status

Operating

Headcount range

11–50 employees

Short description

Parnell Pharmaceuticals is a privately held, founder-operated US specialty pharmaceutical company that develops and markets OTC topical products — Mouth Kote dry mouth spray, Pretz nasal sprays, and DermFresh skin care — built on its patented Yerba Santa extract technology and sold direct-to-consumer, via Amazon, US pharmacy wholesalers, and Canadian distributor McCaughey.

Ownership category

akta.pro rank

Product category

Topical OTC Pharmaceuticals

NAICS

Toilet Preparation Manufacturing (325620), Toilet Preparation Manufacturing (32562)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Oral Care Products (Toothpaste, Mouthwash, Dental Floss, Whitening) (CRADAMAA)

akta.pro secondary industries

Dermatology Specialty Pharmaceuticals (HLAIACAL), Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK), Antibacterial & Medicated Cleansers (e.g., Acne, Antifungal, Antiseptic) (CRABAEAH)

Keywords

• Topical pharmaceutical products
• Dry mouth treatment
• Nasal moisturizing spray
• OTC mucosal care
• Yerba Santa extract

Headquarters

HQ city

San Rafael

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Operations

Revenue model

1. Direct Product Sales: Revenue generated from selling topical formulations and nasal sprays directly to consumers through e-commerce website, phone orders, and retail pharmacy distribution. Products include Mouth Kote, Pretz Nasal Sprays, and DermFresh.
2. Professional/Healthcare Provider Sales: US healthcare providers may request professional accounts with professional pricing and access to additional product samples.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

Parnell Pharmaceuticals develops, manufactures, and markets over-the-counter topical formulations that combat dryness and infections of the mucosa and skin. Its product portfolio centers on patented Yerba Santa extract technology and includes Mouth Kote dry mouth spray, Pretz nasal sprays (original and preservative-free), and DermFresh skin care solution. Products are sold to consumers through e-commerce and pharmacy channels and to US healthcare providers via professional accounts.

Product overview

Parnell Pharmaceuticals is a Lifestyle Health Care Company dedicated to successful aging, providing quality-of-life products designed to combat dryness and infections. The company offers a portfolio of four core topical products all utilizing patented Yerba Santa extract technology: Mouth Kote® Dry Mouth Spray for oral moisture, Pretz® Nasal Spray (original and preservative-free variants) for nasal moisture, and DermFresh for skin care. All products are alcohol-free, gluten-free, sugar-free, and have no animal testing involved. The products are regulated and registered as Class 1 Medical Devices in the USA and EU. Parnell Pharmaceuticals is the only pharmaceutical company that utilizes Yerba Santa in its patented products, which helps provide enhanced moisturization and lubricity through natural mucopolysaccharides that mimic glycoproteins in normal mucosa and skin.

Differentiator

Problem solved

Functional benefit

Brands

• Mouth Kote: Oral moisturizer spray for dry mouth relief containing Yerba Santa. Registered trademark of Parnell Pharmaceuticals, Inc.
• Pretz
• DermFresh

Products and services

• Mouth Kote Dry Mouth Spray Oral moisturizer spray for individuals with xerostomia (dry mouth) caused by medications, disease, surgery, irradiation, Sjogren's Syndrome, or aging; contains Yerba Santa extract, xylitol, and a lemon-lime flavor; sugar-free and alcohol-free.
• Pretz Nasal Spray (original) Moisturizing nasal spray containing Yerba Santa and sea salt, based on the original Dr. Proetz formula of glycerin and saline plus patented Yerba Santa; lubricates and moisturizes nasal membranes, relieves dryness, reduces crusting, and thins secretions; available in 50 ml applicator bottle and 32 oz refill.
• Pretz Nasal Spray (preservative-free) 100% natural, preservative-free moisturizing nasal spray with Yerba Santa and sea salt; 20 ml sterile applicator with no backflow; contains purified water, vegetable glycerin, sea salt, and Yerba Santa buffered to nasal pH.
• DermFresh Refreshing topical solution that removes oils and residues and maintains natural skin pH balance; for use on the face, neck, chest, and hands; designed to prepare skin for cosmetic and laser surgery procedures.

Quantifiable outcome

• In a University of Minnesota study, 83% of patients preferred MouthKote to Xero-Lube Artificial Saliva, 78% preferred MouthKote to Salivart Saliva Substitute or water
• +1 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature2 records

Partnerships

One partnership is on record.

• Dr. Arthur ProetzminorOthersDr. Proetz developed the original 'Pretz Nasal Solution' formula in the early 1900s, consisting of glycerin and saline. The Pretz products are based on this original Dr. Proetz formula with the addition of Yerba Santa. Parnell acknowledges this historical foundation in their product literature.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Xlear: Xlear makes xylitol-based nasal sprays and oral care products and competes most directly with Parnell's Pretz nasal sprays and Mouth Kote in natural saline-style nasal and oral moisturization.
• Salivart (Crosstex): Salivart is a saliva substitute spray for xerostomia relief, directly benchmarked against Mouth Kote in the University of Minnesota preference study referenced in Parnell's data.
• Biotene (Haleon): Biotene is the leading over-the-counter dry-mouth brand (mouthwash, spray, gel) owned by Haleon, directly competing with Parnell's Mouth Kote in the same xerostomia consumer and professional channel.
• B.F. Ascher & Company (Ayr): Ayr saline nasal moisturizing sprays are sold through the same pharmacy wholesalers as Pretz and target the same nasal dryness use case, making B.F. Ascher a direct retail competitor.

Broad incumbents

• CeraVe (L'Oréal): CeraVe is a dermatologist-endorsed skincare brand owned by L'Oréal and overlaps with DermFresh in clinician-recommended skincare, with much larger consumer awareness.
• Church & Dwight (Simply Saline): Simply Saline is a mass-market saline nasal spray line from Church & Dwight, competing with Pretz in the same OTC nasal moisturization category but with significantly larger marketing and distribution.
• Bayer (Ocean Nasal Sprays): Ocean saline nasal sprays, owned by Bayer, compete with Pretz in the same saline nasal moisturization category with much broader retail presence and physician sampling.
• Cetaphil (Galderma): Cetaphil is a leading dermatologist-recommended skin care brand and overlaps with DermFresh in sensitive and pre-procedure skin care, particularly through professional recommendation channels.
• Neutrogena (Johnson & Johnson): Neutrogena's dermatology-oriented skin care portfolio competes broadly with Parnell's DermFresh in OTC dermatology and pre-procedure skin preparation.

Emerging players

• Squip / Heyedrate: Heyedrate and similar niche botanical-branded OTC brands compete in adjacent dryness and mucosal-moisture niches with a comparable DTC, natural-ingredient positioning to Parnell.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/parnell-pharmaceuticals-inc.

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Parnell Pharmaceuticals